可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Tang G, Wu L, Liang W, et al. Direct stimulation of KATP channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells[J]. Mol Pharmacol, 2005, 68(6):1757-1764.
[2] Kubo S, Kurokawa Y, Doe I, et al. Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase[J]. Toxicology, 2007, 241(1-2):92-97.
[3] Lee SW, Cheng Y, Moore PK, et al. Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells[J]. Biochem Biophys Res Commun, 2007, 358(4):1142-1147.
[4] Kiss L, Deitch EA, Szabó C. Hydrogen sulfide decreases adenosine triphosphate levels in aortic rings and leads to vasorelaxation via metabolic inhibition[J]. Life Sciences, 2008, 83(17-18):589-594.
[5] Ali MY, Ping CY, Mok YY, et al. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?[J]. Br J Pharmacol, 2006, 149(6):625-634.
[6] Xiao L, Wu YM, Zhang H, et al. Hydrogen sulfide facilitates carotid sinus baroreflex in anesthetized rats[J]. Acta Pharmacol Sin, 2006, 27(3):294-298.
[7] Dawe GS, Han SP, Bian JS, et al. Hydrogen sulfide in the hypothalamus causes an ATP-sensitive K+ channel-dependent decrease in blood pressure in freely moving rats[J]. Neuroscience, 2008,152(1):169-177.
[8] Yong QC, Pan TT, Hu LF, et al. Negative regulation of beta-adrenergic function by hydrogensulphide in the rat hearts[J]. J Mol Cell Cardiol, 2008, 44(4):701-710.
[9] Zagli G, Patacchini R, Trevisani M, et al. Hydrogen sulfide inhibits human platelet aggregation[J]. Eur J Pharmacol, 2007, 559(1):65-68.
[10]Hongfang J, Cong BL, Zhao B, et al. Effects of hydrogen sulfide on hypoxic pulmonary vascular structural remodeling[J]. Life Sci, 2006, 78(12):1299-1309.
[11]Xiaohui L, Junbao D, Lin S, et al. Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats[J]. Circ J, 2005, 69(11):1418-1424.
[12]Li XH, Du JB, Bu DF, et al. Sodium hydrosulfide alleviated pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats[J]. Acta Pharmacol Sin, 2006, 27(8):971-980.
[13]Li X, Du J, Jin H, et al. The regulatory effect of endogenous hydrogen sulfide on pulmonary vascular structure and gasotransmitters in rats with high pulmonary blood flow[J]. Life Sci, 2007, 81(10):841-849.
[14]Johansen D, Ytrehus K, Baxter GF. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels[J]. Basic Res Cardiol, 2006, 101(1):53-60.
[15]Zhu YZ, Wang ZJ, Ho P, et al. Hydrogen sulfide and its cardioprotective effects in myocardial ischemia in experimental rats[J]. J Appl Physiol, 2007, 102(1):261-268.
[16]Bian JS, Yong QC, Pan TT, et al. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes[J]. J Pharmacol Exp Ther, 2006, 316(2):670-678.
[17]Pan TT, Feng ZN, Lee SW, et al. Endogenous hydrogen sulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes[J]. J Mol Cell Cardiol, 2006, 40(1):119-130.
[18]Sodha NR, Clements RT, Feng J, et al. The effects of therapeutic sulfide on myocardial apoptosis in response to ischemia-reperfusion injury[J]. Eur J Cardiothorac Surg, 2008, 33(5):906-913.
[19]Ji Y, Pang QF, Xu G, et al. Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury [J]. Eur J Pharmacol, 2008, 587(1-3):1-7.